Medicus Pharma (MDCX) Enterprise Value (2023 - 2025)

Medicus Pharma (MDCX) has reported Enterprise Value for 3 consecutive years, with -$8.6 million the latest figure, recorded in Q4 2025.

• Enterprise Value for Q4 2025 came in at -$8.6 million, down 106.52% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8.6 million (down 106.52% YoY), and the FY2025 annual result was -$8.6 million, down 106.52% from the prior year.
• Enterprise Value was -$8.6 million for Q4 2025 at Medicus Pharma, down from -$8.6 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$1.7 million in Q4 2023 and troughed at -$9.7 million in Q2 2025.
• Average Enterprise Value over 3 years is -$6.1 million, with a median of -$6.4 million recorded in 2024.
• Year-over-year, Enterprise Value tumbled 142.21% in 2024 and slumped 106.52% in 2025.
• Over 3 years, Enterprise Value stood at -$1.7 million in 2023, then slumped by 142.21% to -$4.2 million in 2024, then plunged by 106.52% to -$8.6 million in 2025.
• Per Business Quant data, the three most recent Enterprise Value figures were -$8.6 million in Q4 2025, -$8.6 million in Q3 2025, and -$9.7 million in Q2 2025.